{"id":"W2114421863","doi":"10.1016/s0168-8278(10)60033-5","title":"31 SAFETY AND ANTIVIRAL ACTIVITY OF THE HCV NON-NUCLEOSIDE POLYMERASE INHIBITOR VX-222 IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS","year":2010,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"BioPhage Pharma (Canada); University of Ottawa; University of Manitoba; University of British Columbia","funders":"","keywords":"Virology; Genotype; Nucleoside analogue; Medicine; Antiviral treatment; Polymerase; Nucleoside; Biology; Virus; Chronic hepatitis; Gene; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002209399,0.0002043084,0.0005826916,0.0001920588,0.000171706,0.000006457813,0.0002289085,0.0003244783,0.00006085642],"category_scores_gemma":[0.000164587,0.0001367395,0.0001750616,0.0001931885,0.0005004107,0.000153854,0.00009480913,0.0006534154,0.00001135724],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004895576,"about_ca_system_score_gemma":0.0002255438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005370213,"about_ca_topic_score_gemma":0.0001825888,"domain_scores_codex":[0.998578,0.000285952,0.0005836104,0.0001724703,0.00004838151,0.0003315821],"domain_scores_gemma":[0.9988108,0.0001916104,0.0006323569,0.000238184,0.0001160286,0.00001100805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001074522,0.0007305755,0.4798452,0.000008666112,0.0001163066,0.000008377597,0.0007152007,0.000001419578,0.4909745,0.00004315917,0.00003848422,0.02644362],"study_design_scores_gemma":[0.005708008,0.0007863014,0.7787589,0.00003374416,0.00008419459,0.000105969,0.0001061867,0.00001250358,0.2101827,0.00005308652,0.004000671,0.0001677642],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956371,0.0016475,0.000006668472,0.0002956768,0.001735027,0.0001934037,0.00002444887,0.000006068251,0.0004541007],"genre_scores_gemma":[0.9996415,0.0001624604,0.00001327809,0.00007213202,0.000008270854,0.000001914841,0.00000700955,0.00001220318,0.00008121438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2989137,"threshold_uncertainty_score":0.5576074,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003860461092103142,"score_gpt":0.211352978017188,"score_spread":0.2074925169250848,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}